CompuNet Laboratory Critical Values
CompuNet has an established Critical Values policy as defined by Dr. Ronald Chiu, CompuNet medical director. The critical values list has been set for lab results that may pose an immediate health risk or require a provider’s attention. Currently, communication priority levels have been set based on the level of urgency.
P1: The highest level of urgency is Priority 1. If a patient’s lab result falls within the “P1” category, the lab will contact provider 24 hours a day, seven days a week.
P2: Priority 2 results are considered less urgent and the lab will contact the provider during the hours of 9 a.m. to 5 p.m., seven days a week.
P3: Priority 3 results are considered the least urgent; however, a provider will be called by the lab if a patient has a “P3” result from 9 a.m. to 5 p.m., Monday through Friday. Providers will not be paged for “P3” results.
Please note that when CompuNet undergoes its lab information system conversion to Sunquest in April 2020, the priority notification levels will be adjusted.
|
Test |
Units |
Priority 1 |
Priority 2 |
Priority 3 |
Chemistry |
||||
|
Acetaminophen |
mcg/ml |
>100 |
>50 |
|
|
Amikacin Peak |
mcg/ml |
|
>45 |
|
|
Amikacin Trough |
mcg/ml |
|
>8 |
|
|
Amylase |
[U/L] |
|
>299 |
|
|
Bilirubin (Total) <2 years |
mg/dL |
>15. 0 |
12.l - 15.0 |
|
|
Calcium (total) |
mg/dL |
<6.0 or > l 3.0 |
6.0 - 7.5 or 11.5 - 13.0 |
|
|
Carbamazepine |
mcg/ml |
>20 |
12. l - 20.0 |
|
|
Creatinine |
mg/di |
|
>8.0 |
|
|
Digoxin |
ng/ml |
>3.0 |
2.5 - 3.0 |
|
|
Fetal Fibronectin |
|
All Positives |
|
All negatives |
|
Gentamicin Peak/Random |
mcg/ml |
|
>10 |
|
|
Gentamicin Trough |
mcg/ml |
|
>2 |
|
|
Glucose |
mg/dL |
>600 |
< 49 or 500 - 600 |
400-499 |
|
Glucose GTT, Last sample only |
mg/dL |
>600 |
< 49 or 500 - 600 |
400-499 |
|
Lithium |
MEQ/L |
>2.0 |
1.6 - 2.0 |
|
|
MB |
ng/ml |
|
> 8.0 |
|
|
Magnesium |
MEQ/L |
< 1.0 or >5.0 |
|
|
|
Phenobarbital |
mcg/ml |
>60 |
40.1 - 60.0 |
|
|
Phenytoin (Dilantin), Free |
mcg/ml |
>3.0 |
|
|
|
Phenytoin (Dilantin), Total |
mcg/ml |
>40 |
35. l - 40.0 |
|
|
Phosphorus |
mg/dL |
<1.1 |
|
|
|
Potassium (non- dialysis patients) |
MEQ/L |
<2.0 or >6.5 |
2.0 - 3.0 or 6.0 - 6.5 |
|
|
Potassium (AKU dialysis patients or clients with Dialysis in account name) |
MEQ/L |
<2.0 or >7.5 |
2.0 - 3.0 or 7.0 - 7.5 |
|
|
Salicylate |
mg/dL |
> 30 |
|
|
|
Sodium |
MEQ /L |
<115 or >170 |
|
|
|
Theophylline |
mcg/ml |
>40 |
20.1 - 40.0 |
|
|
Tobramycin Peak/Random |
mcg/ml |
|
> 10.0 |
|
|
Tobramycin Trough |
mcg/ml |
|
>2.0 |
|
|
Troponin T |
ng/ml |
>= 0.01 |
|
|
|
Valproic Acid |
mcg/ml |
>150 |
101 - 150 |
|
|
Vancomycin Peak/Random |
mcg/ml |
>80 |
40- 80 |
|
|
Vancomycin Trough |
mcg/ml |
>80 |
>20 |
|
Hematology and Coagulation |
||||
|
Absolute Neutrophils |
K/mm3 |
|
< 1.0 |
|
|
ADAMTS13 Activity |
% |
|
<10 |
|
|
Factor VIII |
% |
<1.0 Q=No Pl |
<5.0 |
|
|
Factor IX |
% |
<1.0 Q=No Pl |
<5.0 |
|
|
HGB <12 yrs |
g/dL |
< 7.0 or >22.5 |
7.0 - 8.9 |
|
|
HGB >12 yrs |
g/dL |
<6.0 |
6.0 - 7.0 |
|
|
Platelet |
K/mmJ |
<20 or >1500 |
20 - 49 or 1000 - 1500 |
|
|
WBC (known CLL=P3) |
K/mmJ |
<0.5 or > 100 |
0.5 - 1.0 or 20 - 100 |
|
|
APTT |
seconds |
> 60.0 |
|
|
|
Fibrinogen |
mg/dL |
|
<50 |
|
|
INR (Prothombin Time, PT) |
none |
> 8.0 |
5.0- 8.0 |
4.1-4 .9 |
|
Blasts |
|
20% |
Any quantity on previously undiagnosed leukemic; increase of >2.5x on known leukemic |
|
|
Organisms |
|
Intracellular |
|
|
|
HIPA (Heparin Induced Platelet antibody) |
|
Positive |
|
|
Microbiology |
||||
|
Sterile body fluid gram stain |
|
Positive |
|
|
|
Cryptococcal Antigen (FTR*) |
|
Positive |
|
|
|
AFB smear |
|
|
Positive |
|
|
KOH (tissue or Bronch specimen) |
|
|
Positive |
|
|
KOH/Calcafluor preparations suggestive of Blastomyces or |
|
Positive |
|
|
|
Malaria smear |
|
Positive |
|
|
|
Blood culture |
|
Positive |
|
|
|
CSF culture |
|
Positive |
|
|
|
Pleural, joint, peritoneal culture |
|
Positive |
|
|
|
Pure or predominant |
|
|
Positive |
|
|
Brucella or Francisella (culture) |
|
|
Positive |
|
|
AFB culture |
|
|
Positive |
|
|
Nocardia, dimorphic |
|
|
Positive |
|
|
Fecal Pathogens (SSCY, Ecoli 0157, Rotovirus, parasites (except |
|
|
Positive |
|
|
C. difficile (MVH inpatient only) |
|
|
Positive |
|
|
Foreign body culture |
|
|
Positive |
|
|
NICU cultures with yeast |
|
|
Positive |
|
|
Gp B strep from maternity, LD, NICU, nurseries |
|
|
Positive |
|
|
Yersinia Pestis, culture, nucleic acid or antigen test |
|
|
Positive |
|
|
Gp A Streptococci |
|
|
Positive |
|
|
RSV |
|
|
Positive |
|
|
Legionella antigen or culture |
|
|
Positive |
|
|
Cryptosporidium DFA |
|
|
Positive |
|
|
Chlamydia |
|
|
Positive |
|
|
GC |
|
|
Positive |
|
|
HSV from CSF or neonate |
|
Positive |
|
|
|
HSV (Other Sites) |
|
|
Positive |
|
|
CSF Antigen or PCR |
|
Positive |
|
|
|
Virus isolation or direct antigen test |
|
|
Positive |
|
|
Pneumocystis carinii |
|
|
Positive |
|
|
Bordetella Pertussis |
|
|
Positive |
|
|
MRSA |
|
|
Positive faxed to infection |
|
|
Cytology |
|
|
|
|
|
GYN-pap cases |
|
|
HGSIL and above |
|
|
Surg Path - See Surg path procedure |
||||
Back to the January 2020 issue of Premier Pulse
